ASCO 2023   

Questions discussed in this category


What were your “top 3” presentations/studies coming out of the meeting this year and how will it impact your own clinical practice? ...

Given the recent update from the NAPOLI-3 trial presented at GI ASCO 2023, the two regimens appear to have similar OS.

Especially as the study was done before the adoption of total neoadjuvant therapy

How are you incorporating CONTACT-03 data presented at #ASCO2023 (Pal et al., PMID 37290461) into your practice? Would you consider immunotherapy re-c...


Papers discussed in this category


N. Engl. J. Med.,

JAMA network open, 2024 Jan 02

The New England journal of medicine, 2013-10-31

N. Engl. J. Med.,

Lancet, 2021 Jun 05

Eur J Cancer, 2018 Aug 24

NEJM Evidence, 2022 Jun 1

J Clin Oncol, 2019 Sep 26

Ann Surg, 2023 Jan 20

Ann Oncol, 2022 Oct 25

J Clin Oncol, 2023 Jun 04

N Engl J Med, 2023 Jun 04

N. Engl. J. Med., 2004-10-21

JAMA oncology, 2018-06-14

Lancet Oncol, 2021 Apr 13

J Clin Oncol, 2022 Apr 28

Ann Surg, 2020 Mar

Future Oncol, 2020 Apr 30

Lancet, 2021 Jun 24

N Engl J Med, 2023 Jun 05

N Engl J Med, 2023 Feb 10

Lancet Oncol, 2021 Dec 03

Lancet, 2021 Jun 04

Lancet, 2023 Jun 02

Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2020 Oct 27

Cancer medicine, 2022 Feb 09

Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2022 Apr 20

Clinical genitourinary cancer, 2020 Oct 15

Journal for immunotherapy of cancer, 2023 Mar

N Engl J Med, 2022 Apr 11

N Engl J Med, 2017 Nov 16

N Engl J Med, 2021 Jun 04

N Engl J Med, 2023 Jun 28

Lancet Oncol, 2021 May 04

Lancet Oncol, 2023 Jun 02

Lancet Oncol., 2015 Sep 09

J Clin Oncol, 2022 Jan 07

J Am Coll Surg, 2021 Sep 13

J. Clin. Oncol., 2020 Sep 20

Leukemia, 2014-03

Lancet Oncol, 2021 Nov 11

Blood, 2022 Oct 20

N Engl J Med, 2023 Jun 05

N Engl J Med, 2023 Mar 27

The New England journal of medicine, 2018-11-15

Int J Gynecol Cancer, 2021 Sep 07

J Clin Oncol, 2023 Jan 30